Announcements Trials

Browse Landscape

Phase

Status

Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Specimen Handling 116 Magnetic Resonance Spectroscopy 78 Biopsy 69 Cyclophosphamide 24 pembrolizumab 22 Cisplatin 21 fludarabine 18 Platinum 17 1,2-diaminocyclohexaneplatinum II citrate 17 Taxes 16 Paclitaxel 16 Carboplatin 16 Nivolumab 15 Immunoglobulin G 14 Disulfides 14 X-Rays 13 Radiation 13 Doxorubicin 12 venetoclax 11 Radiotherapy 11 Gemcitabine 11 durvalumab 9 cabozantinib 8 aldesleukin 8 Prednisone 8 atezolizumab 7 Cytarabine 7 olaparib 6 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NIH × TAK-243 × Clear all

NCT06223542 2026-05-13

Studying TAK-243 in Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡